| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Tvardi Therapeutics, Inc.
13G/A
TVRD · 140755307
|
4.5% |
2/17/2026
Event 12/31/2025
|
||||
|
Tvardi Therapeutics, Inc.
13G/A
CARA · 140755208
|
6.7% |
11/14/2025
Event 9/30/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.